Bioalpha Holdings Bhd (0179) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.084x

Based on the latest financial reports, Bioalpha Holdings Bhd (0179) has a cash flow conversion efficiency ratio of -0.084x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RM-5.83 Million ≈ $-1.46 Million USD) by net assets (RM69.43 Million ≈ $17.43 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Bioalpha Holdings Bhd's balance sheet to measure how much of total assets are equity-financed.

Bioalpha Holdings Bhd - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Bioalpha Holdings Bhd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Bioalpha Holdings Bhd to evaluate the quality of earnings relative to operating cash generation.

Bioalpha Holdings Bhd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bioalpha Holdings Bhd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
20/20 Biolabs, Inc. Common Stock
NASDAQ:AIDX
-4.946x
Masivo Silver Corp
V:MASS
-10.665x
Rank Group PLC
LSE:RNK
0.130x
Llama Group S.A.
PA:ALLAM
0.411x
Polar Capital Global Healthcare Trust plc
LSE:PCGH
-0.003x
London Security Plc
LSE:LSC
0.108x
Shin Hwa Silup
KO:001770
-0.042x
SMX (Security Matters) Public Limited Company Class A Ordinary Shares
NASDAQ:SMX
0.000x

Annual Cash Flow Conversion Efficiency for Bioalpha Holdings Bhd (2015–2025)

The table below shows the annual cash flow conversion efficiency of Bioalpha Holdings Bhd from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Bioalpha Holdings Bhd worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 RM69.43 Million
≈ $17.43 Million
RM-11.66 Million
≈ $-2.93 Million
-0.168x -18666.67%
2024-12-31 RM98.34 Million
≈ $24.69 Million
RM88.94K
≈ $22.33K
0.001x -95.28%
2023-12-31 RM127.37 Million
≈ $31.98 Million
RM2.44 Million
≈ $612.64K
0.019x +159.94%
2022-12-31 RM167.86 Million
≈ $42.14 Million
RM-5.37 Million
≈ $-1.35 Million
-0.032x -60.95%
2021-12-31 RM186.67 Million
≈ $46.87 Million
RM-3.71 Million
≈ $-930.73K
-0.020x -94.82%
2020-12-31 RM160.90 Million
≈ $40.40 Million
RM-1.64 Million
≈ $-411.77K
-0.010x -110.37%
2019-12-31 RM165.55 Million
≈ $41.56 Million
RM16.27 Million
≈ $4.08 Million
0.098x -24.50%
2018-12-31 RM157.62 Million
≈ $39.57 Million
RM20.51 Million
≈ $5.15 Million
0.130x -56.34%
2017-12-31 RM135.44 Million
≈ $34.00 Million
RM40.37 Million
≈ $10.14 Million
0.298x +875.06%
2016-12-31 RM97.99 Million
≈ $24.60 Million
RM3.00 Million
≈ $752.05K
0.031x -54.27%
2015-12-31 RM79.00 Million
≈ $19.84 Million
RM5.28 Million
≈ $1.33 Million
0.067x --

About Bioalpha Holdings Bhd

KLSE:0179 Malaysia Packaged Foods
Market Cap
$5.30 Million
RM21.10 Million MYR
Market Cap Rank
#28473 Global
#929 in Malaysia
Share Price
RM0.02
Change (1 day)
-25.00%
52-Week Range
RM0.01 - RM0.03
All Time High
RM0.35
About

Bioalpha Holdings Berhad, an investment holding company, manufactures and sells health supplement products in Malaysia, China, and internationally. It operates through Trading and Manufacturing segments. The company also engages in the provision of advertising and promotion services for health supplements, nutrition products, personal care, functional food, and healthcare products; import, export… Read more